47 related articles for article (PubMed ID: 36160072)
1. Management of Autoimmune Encephalitis in a 7-Year-Old Child With CTLA-4 Haploinsufficiency and AMPA Receptor Antibodies: A Case Report.
Quaak MSW; Buijze MSJS; Verhoeven VJM; Vermont C; Buddingh EP; Heredia M; Samsom JN; Titulaer MJ; van Rossum AM; Kamphuis S; Neuteboom RF
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200254. PubMed ID: 38728609
[TBL] [Abstract][Full Text] [Related]
2. What did we learn from CTLA-4 insufficiency on the human immune system?
Mitsuiki N; Schwab C; Grimbacher B
Immunol Rev; 2019 Jan; 287(1):33-49. PubMed ID: 30565239
[TBL] [Abstract][Full Text] [Related]
3. Immune checkpoint deficiencies and autoimmune lymphoproliferative syndromes.
Gámez-Díaz L; Grimbacher B
Biomed J; 2021 Aug; 44(4):400-411. PubMed ID: 34384744
[TBL] [Abstract][Full Text] [Related]
4. A Rare Central Nervous System Involvement Due to CTLA-4 Gene Defect.
Rovshanov S; Göçmen R; Barişta İ; Çağdaş D; Üner A; Çilingir V; Filik İT; Tan Ç; Aytekin ES; Tezcan İ; Özen PA; Tuncer A
Noro Psikiyatr Ars; 2022; 59(3):248-252. PubMed ID: 36160072
[TBL] [Abstract][Full Text] [Related]
5. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
6. An Activating Janus Kinase-3 Mutation Is Associated with Cytotoxic T Lymphocyte Antigen-4-Dependent Immune Dysregulation Syndrome.
Sic H; Speletas M; Cornacchione V; Seidl M; Beibel M; Linghu B; Yang F; Sevdali E; Germenis AE; Oakeley EJ; Vangrevelinghe E; Sailer AW; Traggiai E; Gram H; Eibel H
Front Immunol; 2017; 8():1824. PubMed ID: 29375547
[TBL] [Abstract][Full Text] [Related]
7. A Patient with CTLA-4 Haploinsufficiency with Multiple Autoimmune Presentations: A Case Report.
Zaremehrjardi F; Baniadam L; Seif F; Arshi S; Bemanian MH; Shokri S; Rezaeifar A; Fallahpour M; Nabavi M
Iran J Immunol; 2020 Sep; 17(3):244-249. PubMed ID: 32996901
[TBL] [Abstract][Full Text] [Related]
8. Neurological manifestation of immune system dysregulation resulting from CTLA-4 receptor mutation: a case report.
Kolcava J; Litzman J; Bednarik J; Stulik J; Stourac P
Mult Scler Relat Disord; 2020 Oct; 45():102313. PubMed ID: 32623363
[TBL] [Abstract][Full Text] [Related]
9. Two neurologic facets of CTLA4-related haploinsufficiency.
Ayrignac X; Goulabchand R; Jeziorski E; Rullier P; Carra-Dallière C; Lozano C; Portales P; Vincent T; Viallard JF; Menjot de Champfleur N; Rieux-Laucat F; Besnard C; Koenig M; Guissart C; Labauge P; Guilpain P
Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32499327
[TBL] [Abstract][Full Text] [Related]
10. Immune dysregulation syndrome with de novo CTLA4 germline mutation responsive to abatacept therapy.
Ureshino H; Koarada S; Kamachi K; Yoshimura M; Yokoo M; Kubota Y; Ando T; Ichinohe T; Morio T; Kimura S
Int J Hematol; 2020 Jun; 111(6):897-902. PubMed ID: 31993940
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Intracerebral Lesions with Abatacept in a CTLA4-Haploinsufficient Patient.
van Leeuwen EM; Cuadrado E; Gerrits AM; Witteveen E; de Bree GJ
J Clin Immunol; 2018 May; 38(4):464-467. PubMed ID: 29796761
[No Abstract] [Full Text] [Related]
12. Course of IL-2-inducible T-cell kinase deficiency in a family: lymphomatoid granulomatosis, lymphoma and allogeneic bone marrow transplantation in one sibling; and death in the other.
Çağdaş D; Erman B; Hanoğlu D; Tavil B; Kuşkonmaz B; Aydın B; Akyüz C; Uçkan D; Sanal Ö; Tezcan I
Bone Marrow Transplant; 2017 Jan; 52(1):126-129. PubMed ID: 27454071
[No Abstract] [Full Text] [Related]
13. CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition.
Buchbinder EI; Desai A
Am J Clin Oncol; 2016 Feb; 39(1):98-106. PubMed ID: 26558876
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
